ECVAM: the European Centre for the Validation of Alternative Methods.

The European Centre for the Validation of Alternative Methods (ECVAM) has recently been established. The Centre will co-ordinate at Community level the validation of alternative test methods, maintain a database and act as a focal point for the exchange of information on alternative procedure, and carry out research and training. ECVAM aims to promote dialogue between legislators, industries, biomedical scientists, consumer organisations and animal welfare groups with a view to the development, validation and international recognition of alternative test methods.

[1]  C. Hendriksen,et al.  The Production of Monoclonal Antibodies: Are Animals Still Needed? , 1996 .

[2]  Spielmann Horst,et al.  Practical Aspects of the Validation of Toxicity Test Procedures , 1995 .

[3]  Balls Michael,et al.  The Validation of Alternative Test Methods , 1996 .

[4]  I. Ruhdel,et al.  Monoclonal Antibodies: In Vivo and In Vitro Production on a Laboratory Scale, with Consideration of the Legal Aspects of Animal Protection , 1989, ALTEX.

[5]  U. Marx,et al.  Glycosylation analysis of a polyreactive human monoclonal IgG antibody derived from a human-mouse heterohybridoma. , 1995, Molecular immunology.

[6]  U von Stockar,et al.  Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production. , 1996, Journal of Biotechnology.

[7]  U. Marx,et al.  In vivo and in vitro production of monoclonal antibodies. Bioreactors vs immune ascites. , 1995, Methods in molecular biology.

[8]  Michael Balls,et al.  Report and Recommendations of the CAAT 1 /ERGATT 2 Workshop on the Validation of Toxicity Test Procedures 3 , 1990 .

[9]  U. Marx,et al.  Purification and immunochemical characterization of a natural human polyreactive monoclonal IgM antibody. , 1994, Journal of immunological methods.

[10]  D Lowrey,et al.  A comparison of monoclonal antibody productivity in different hollow fiber bioreactors. , 1994, Journal of biotechnology.

[11]  E. Shacter.  Serum-free media for bulk culture of hybridoma cells and the preparation of monoclonal antibodies , 1989 .

[12]  H. Fiebig,et al.  In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter. , 1995, Journal of immunological methods.

[13]  D. J. Asai,et al.  Making monoclonal antibodies. , 1993, Methods in cell biology.